Hongnan Mo

10PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 07, 2026
Overall Survival With Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer: A Single-Center Pooled Analysis.

|Jul 21, 2026
Dalpiciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer and visceral crisis: a multicenter, nonrandomized, phase 2 DARVIN trial.

|Mar 30, 2026
Machine learning survival model for personalised prevention of catheter-related thrombosis in tumour patients.

Hewei Ge, Qiao Liu, Junying Xie

|Mar 14, 2026
Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis.

Yuqiu Li, Hongnan Mo

|Feb 02, 2026
Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel.

Yuqi Xing, Ruiqi Zhong, Qianchen Li

|Dec 11, 2025
Biologically-informed integration of drug representations for breast cancer treatment using deep learning.

Hewei Ge, Hongnan Mo, Yuhan Wei

Pageof 2

Frequent Collaborators

8 joint publications

Fei Ma

3 joint publications

Hewei Ge

2 joint publications

Yuhan Wei

2 joint publications

Haili Qian